Increased skeletal muscle volume in women with familial partial lipodystrophy, dunnigan variety

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 8, 2013, Pages

  Ji, Hongzhao ^a   Weatherall, Paul ^a   Adams Huet, Beverley ^a   Garg, Abhimanyu ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARM MUSCLE; ARTICLE; BODY HEIGHT; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; FAMILIAL PARTIAL LIPODYSTROPHY; FEMALE; HUMAN; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; LEG MUSCLE; LIMB; MAJOR CLINICAL STUDY; MUSCLE MASS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSOAS MUSCLE; SKELETAL MUSCLE; THIGH;

ABSORPTIOMETRY, PHOTON; ADOLESCENT; ADULT; AGED; BODY MASS INDEX; FEMALE; HUMANS; LIPODYSTROPHY, FAMILIAL PARTIAL; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MUSCLE, SKELETAL;

EID: 84881487422     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-1297     Document Type: Article

References (19)

1. Garg A, Vinaitheerthan M, Weatherall PT, Bowcock AM. Phenotypic heterogeneity in patients with familial partial lipodystrophy (Dunnigan variety) related to the site of missense mutations in lamin a/c gene. J Clin Endocrinol Metab. 2001;86:59-65.
2. Haque WA, Vuitch F, Garg A. Post-mortem findings in familial partial lipodystrophy, Dunnigan variety. Diabet Med. 2002;19: 1022-1025.
3. Hoshikawa Y, Muramatsu M, Iida T, Ii N, Nakajima Y, Kanehisa H. Sex differences in the cross-sectional areas of psoas major and thigh muscles in high school track and field athletes and nonathletes. J Physiol Anthropol. 2011;30:47-53.
4. Harrison LC, Martin FI, Melick RA. Correlation between insulin receptor binding in isolated fat cells and insulin sensitivity in obese human subjects. J Clin Invest. 1976;58:1435-1441.
5. Rankin J, Ellard S. The laminopathies: a clinical review. Clin Genet. 2006;70:261-274.
6. Spuler S, Kalbhenn T, Zabojszcza J, et al. Muscle and nerve pathology in Dunnigan familial partial lipodystrophy. Neurology. 2007; 68:677-683.
7. Worman HJ, Bonne G. "Laminopathies": a wide spectrum of human diseases. Exp Cell Res. 2007;313:2121-2133.
8. Garg A, Stray-Gundersen J, Parsons D, Bertocci LA. Skeletal muscle morphology and exercise response in congenital generalized lipodystrophy. Diabetes Care. 2000;23:1545-1550.
9. Vantyghem MC, Pigny P, Maurage CA, et al. Patients with familial partial lipodystrophy of the Dunnigan type due to aLMNAR482W mutation show muscular and cardiac abnormalities. J Clin Endocrinol Metab. 2004;89:5337-5346.
10. Favreau C, Higuet D, Courvalin JC, Buendia B. Expression of a mutant lamin A that causes Emery-Dreifuss muscular dystrophy inhibits in vitro differentiation of C2C12 myoblasts. Mol Cell Biol. 2004;24:1481-1492.
11. Jacob KN, Garg A. Laminopathies: multisystem dystrophy syndromes. Mol Genet Metab. 2006;87:289-302.
12. Worman HJ, Ostlund C, Wang Y. Diseases of the nuclear envelope. Cold Spring Harb Perspect Biol. 2010;2:a000760.
13. Shavlakadze T, Grounds M. Of bears, frogs, meat, mice and men: complexity of factors affecting skeletal muscle mass and fat. Bioessays. 2006;28:994-1009.
14. Coffer PJ, Jin J, Woodgett JR. Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem J. 1998;335(Pt 1):1-13.
15. Glass DJ. Skeletal muscle hypertrophy and atrophy signaling pathways. Int J Biochem Cell Biol. 2005;37:1974-1984.
16. Mario FM, do Amarante F, Toscani MK, Spritzer PM. Lean muscle mass in classic or ovulatory PCOS: association with central obesity and insulin resistance. Exp Clin Endocrinol Diabetes. 2012;120: 511-516.
17. Huang A, Brennan K, Azziz R. Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria. Fertil Steril. 2010;93:1938-1941.
18. Pan DA, Lillioja S, Kriketos AD, et al. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes. 1997;46:983-988.
19. Boschmann M, Engeli S, Moro C, et al. LMNA mutations, skeletal muscle lipid metabolism, and insulin resistance. J Clin Endocrinol Metab. [Erratum 2010;95:2521] 2010;95:1634-1643.